Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Immunotherapy increases survival in some patients with metastatic triple negative breast cancer

Immunotherapy improves survival in some patients with metastatic triple negative breast cancer, according to late-breaking results from the IMpassion130 trial reported at the ESMO 2018 Congress in Munich.

22 Oct 2018

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda Pharmaceutical Company Limited today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients.

22 Oct 2018

ApoE4 gene linked with chronic inflammation increases risk for Alzheimer's disease

While it is widely shown that possessing the ApoE4 gene is the major genetic risk factor of Alzheimer's disease, not all ApoE4 carriers develop AD.

20 Oct 2018

Could we prevent Alzheimer's disease by treating herpes?

An exciting new paper suggests that over half of all cases of Alzheimer’s disease could be traced back to herpes simplex virus 1, which causes cold sores.

19 Oct 2018

Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics

Some bacterial pathogens, including those that cause strep throat and pneumonia, are able to create the components necessary to replicate their DNA without the usually required metal ions.

19 Oct 2018

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

Researchers from City of Hope, a world-renowned comprehensive cancer center and independent biomedical research institution, have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer.

19 Oct 2018

UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery

UT Southwestern biochemist Dr. Zhijian "James" Chen today was named winner of the prestigious 2019 Breakthrough Prize in Life Sciences for his discovery of the cGAS enzyme that launches the body's immune defense against infections and cancers.

19 Oct 2018

Scripps researchers successfully test potential new smoking-cessation treatment in rodents

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

19 Oct 2018

New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses

Researchers developed a novel DNA influenza vaccine based on four micro-consensus antigenic regions selected to represent the diversity of seasonal H3N2 viruses across decades.

18 Oct 2018

Cases of Acute Flaccid Myelitis on the rise across U.S.

According to the Centre for Disease Prevention and Control (CDC), cases of dangerous and rare Acute Flaccid Myelitis (AFM) are being noted across United States. This disease manifests similar to acute flaccid paralysis caused by polio virus say the experts. There is at present no treatment for this condition that primarily affects children and leads to paralysis of the limbs.

18 Oct 2018

Researchers propose skin hardness as physiological sign to estimate human thermal status

Under the same temperature and humidity, human thermal status may vary due to individual body constitution and climatic environment.

17 Oct 2018

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.

16 Oct 2018

Who knew? Life begins (again) at 65

I was convinced I would become an adult when I turned 21. But now, I'm certain that turning 65 was the watershed moment that finally grew me up.

15 Oct 2018

Many parents still skeptical about safety and effectiveness of flu shot, survey finds

When a child gets the flu, they're not only sick in bed for a week or more, but the illness can also have serious and even life-threatening consequences.

15 Oct 2018

Report: Half of parents say young children are afraid of doctor's visits

A trip to the pediatrician's office can be a nerve-wracking experience for both children and their parents, especially when efforts to calm young patients down dominate the visit.

15 Oct 2018

First-of-its-kind study to test a personalized vaccine in cancer patient

Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic.

15 Oct 2018

Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism

A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.

15 Oct 2018

More parents are concerned about taking babies swimming in public pools

Health risks make up over half of parents’ concerns about taking babies swimming in public pools, according to survey findings.

12 Oct 2018

Synspira’s abstracts accepted for presentation at the 32nd Annual NACFC

Synspira, a privately held company developing a new class of inhaled glycopolymer-based therapeutics for the treatment of pulmonary disease, today announced that three abstracts have been accepted for presentation at the 32nd Annual North American Cystic Fibrosis Conference, occurring October 18-20 in Denver, CO.

12 Oct 2018

New standard of care aims to prevent deaths caused by largely preventable blood clots

A new nationally agreed standard of care released today (Thursday) aims to reduce the tens of thousands of Australian lives put at risk each year by largely preventable blood clots, which kill four times more people than road accidents.

12 Oct 2018

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Immunotherapy increases survival in some patients with metastatic triple negative breast cancer

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

ApoE4 gene linked with chronic inflammation increases risk for Alzheimer's disease

Could we prevent Alzheimer's disease by treating herpes?

Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery

Scripps researchers successfully test potential new smoking-cessation treatment in rodents

New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses

Cases of Acute Flaccid Myelitis on the rise across U.S.

Researchers propose skin hardness as physiological sign to estimate human thermal status

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Who knew? Life begins (again) at 65

Many parents still skeptical about safety and effectiveness of flu shot, survey finds

Report: Half of parents say young children are afraid of doctor's visits

First-of-its-kind study to test a personalized vaccine in cancer patient

Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism

More parents are concerned about taking babies swimming in public pools

Synspira’s abstracts accepted for presentation at the 32nd Annual NACFC

New standard of care aims to prevent deaths caused by largely preventable blood clots

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in